| Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials S Walesch, J Birkelbach, G Jézéquel, FPJ Haeckl, JD Hegemann, ... EMBO reports 24 (1), e56033, 2023 | 102 | 2023 |
| Cytotoxic Prenylated Stilbenes Isolated from Macaranga tanarius T Péresse, G Jézéquel, PM Allard, VC Pham, DTM Huong, F Blanchard, ... Journal of natural products 80 (10), 2684-2691, 2017 | 56 | 2017 |
| Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa C Kaya, I Walter, A Alhayek, R Shafiei, G Jézéquel, A Andreas, ... ACS Infectious Diseases 8 (5), 1010-1021, 2022 | 15 | 2022 |
| The Structures and Binding Modes of Small-Molecule Inhibitors of Pseudomonas aeruginosa Elastase LasB V Camberlein, G Jézéquel, J Haupenthal, AKH Hirsch Antibiotics 11 (8), 1060, 2022 | 10 | 2022 |
| Structure-Based Design of a Lead Compound Derived from Natural Schweinfurthins with Antitumor Properties That Target Oxysterol-Binding Protein G Jézéquel, C Rampal, C Guimard, D Kovacs, J Polidori, J Bigay, ... Journal of Medicinal Chemistry 66 (20), 14208-14220, 2023 | 6 | 2023 |
| Synthesis and anti-leishmanial properties of quinolones derived from zanthosimuline G Jézéquel, LNF Cardoso, F Olivon, I Dennemont, C Apel, M Litaudon, ... Molecules 27 (22), 7892, 2022 | 2 | 2022 |
| Target-Directed Dynamic Combinatorial Chemistry Affords Binders of Mycobacterium tuberculosis IspE M Braun-Cornejo, C Ornago, V Sonawane, J Haupenthal, AM Kany, ... ACS omega, 2024 | | 2024 |
| Funktionalisierung von Chlorotonilen: Dehalogenil als vielversprechende Leitverbindung für die in vivo‐Anwendung W Hofer, F Deschner, G Jézéquel, L Pessanha de Carvalho, ... Angewandte Chemie 136 (19), e202319765, 2024 | | 2024 |
| Functionalization of Chlorotonils: Dehalogenil as Promising Lead Compound for In Vivo Application W Hofer, F Deschner, G Jézéquel, L Pessanha de Carvalho, ... Angewandte Chemie International Edition 63 (19), e202319765, 2024 | | 2024 |
| Bio-inspired synthesis and profiling of a potent antiviral flavonol targeting the lipid exchanger OSBP G Jézéquel, Z Grimanelli, C Guimard, J Bigay, J Haddad, J Bignon, ... | | 2024 |
| Target-directed dynamic combinatorial chemistry affords inhibitors of Nsp10 as potential antivirals against SARS-CoV-2 RP Jumde, G Jézéquel, M Saramago, N Frank, S Adam, MV Cunha, ... | | 2023 |
| Process for the biobased synthesis of schweinfurthins G, K and R M Litaudon, F Roussi, S Desrat, G Jézéquel, C Rampal, HDT Mai | | 2023 |
| Efficient synthetic strategy to access analogues of an original natural bioactive flavone C Guimard, G Jézéquel, L Askenatzis, B Mesmin, J Bignon, S Desrat, ... Journées de Chimie Organique (JCO) 2022, 2022 | | 2022 |
| Targeting OSBP degradation by PROTACs derived from schweinfurthin for cancer therapy C Guimard, G Jézéquel, L Askenatzis, J Bignon, S Desrat, F Roussi 27th EFMC International Symposium on Medicinal Chemistry, 2022 | | 2022 |
| Compound of the 7a, 8, 9, 10, 11, 11a-hexahydro-1H, 7H-pyrano [2, 3-c] xanthene type, method of preparation thereof, intermediates thereof and therapeutic applications thereof F Roussi, S Desrat, G Jézéquel, M Litaudon, J Bignon, B Mesmin, ... | | 2022 |
| Novel process for the biobased synthesis of Schweinfurthins G, K and R. F Roussi, M Litaudon, S Desrat, C Rampal, G Jézéquel, CP Van, ... | | 2022 |
| Structure-based design of a-substituted mercaptoacetamides as inhibitors of the virulence factor LasB from Pseudomonas aeruginosa. C Kaya, I Walter, A Alhayek, R Shafiei, G Jézéquel, A Andreas, ... | | 2022 |
| Synthèse et pharmacomodulation de composés antitumoraux naturels à motif hexahydroxanthène G Jezequel Université Paris-Saclay (ComUE), 2019 | | 2019 |
| New dual molecules as an innovative strategy against glioblastoma: synthesis and biological evaluation G Jézéquel, T Péresse, T Virolle, J Bignon, S Desrat, F Roussi 8th EFMC International Symposium on Advances in Synthetic and Medicinal …, 2019 | | 2019 |
| Dual molecule to enhance biological activity of an anticancer drug targeting glioblastoma G Jézéquel, T Péresse, M Litaudon, T Virolle, J Bignon, S Desrat, ... 16th Belgian Organic Synthesis Symposium (BOSS), 2018 | | 2018 |
